2m 2m 2m 2m 2m 2m 2m
Cardinal Health (CAH)
NYSE
$224.05+$1.31 (+0.59%)
Price as of Jun 23, 2026 6:03 PM EDT- $52.2BMarket Cap
- 37.36%1-Year Change
- Medical DistributionIndustry
Cardinal Health (CAH)
$224.05+$1.31 (+0.59%)
Annual
Quarterly
06/30/2025 | 06/30/2024 | 06/30/2023 | 06/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 222.6B -1.87% | 226.8B +10.64% | 205.0B +13.04% | 181.4B +11.63% | |
Cost of Revenue | 214.4B -2.28% | 219.4B +10.75% | 198.1B +13.33% | 174.8B +12.29% | |
Gross Profit | 8.2B +10.17% | 7.4B +7.62% | 6.9B +5.26% | 6.5B -3.44% | |
Sales and Marketing Expense | 5.4B +7.64% | 5.0B +3.43% | 4.8B +6.08% | 4.6B +0.53% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 790.0M +11.27% | 710.0M +2.60% | 692.0M 0.00% | 692.0M -11.62% | |
Total Operating Expenses | 214.4B -2.28% | 219.4B +10.75% | 198.1B +13.33% | 174.8B +12.29% | |
Operating Profit | 2.3B +83.02% | 1.2B +70.98% | 727.0M +221.98% | -596.0M -226.27% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -215.0M +321.57% | -51.0M -45.16% | -93.0M -37.58% | -149.0M -17.22% | |
Interest Income and Expense and Net | -215.0M +321.57% | -51.0M -45.16% | -93.0M -37.58% | -149.0M -17.22% | |
Total Nonoperating Income and Expense | 41.0M +355.56% | 9.0M +125.00% | 4.0M +125.00% | -16.0M -134.04% | |
Income before Taxes | 2.1B +74.94% | 1.2B +88.24% | 638.0M +182.96% | -769.0M -338.08% | |
Income Taxes | 532.0M +52.87% | 348.0M -7.45% | 376.0M +130.67% | 163.0M +156.40% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 1.6B +83.22% | 852.0M +226.44% | 261.0M +127.97% | -933.0M -252.70% | |
Net Income from Continuing Operations Applicable to Common | 2.1B +74.94% | 1.2B +88.24% | 638.0M +182.96% | -769.0M -225.86% | |
Basic EPS and Net Income | 6.48 +86.21% | 3.48 +248.00% | 1.00 +129.85% | -3.35 -260.29% | |
Diluted EPS and Net Income | 6.45 +86.96% | 3.45 +245.00% | 1.00 +129.85% | -3.35 -261.06% | |
Basic Weighted Average Shares | 241.0M -1.63% | 245.0M -6.13% | 261.0M -6.45% | 279.0M -4.45% | |
Diluted Weighted Average Shares | 242.0M -2.02% | 247.0M -5.73% | 262.0M -6.09% | 279.0M -5.10% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.9B -24.53% | 5.1B +26.96% | 4.0B -14.29% | 4.7B +38.45% | |
Short-Term Investments | N/A N/A | 200.0M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.9B -27.36% | 5.3B +31.91% | 4.0B -14.29% | 4.7B +38.45% | |
Total Current Assets | 36.4B +4.27% | 34.9B +3.11% | 33.8B +2.73% | 32.9B +6.08% | |
Accumulated Depreciation | 4.7B +11.81% | 4.2B +8.01% | 3.9B +9.51% | 3.5B +9.11% | |
Property and Plant and Equipment and Net | 2.9B +13.01% | 2.5B +2.72% | 2.5B +4.28% | 2.4B +0.04% | |
Total Long-Term Assets | 1.7B +36.25% | 1.3B +20.85% | 1.0B +9.23% | 953.0M +0.21% | |
Total Assets | 53.1B +17.73% | 45.1B +3.92% | 43.4B -1.05% | 43.9B -1.29% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 550.0M +26.73% | 434.0M -45.20% | 792.0M +36.55% | 580.0M -33.41% | |
Total Current Liabilities | 38.9B +9.14% | 35.6B +5.74% | 33.7B +10.33% | 30.6B +10.59% | |
Total Long-Term Debt | 8.0B +71.25% | 4.7B +19.16% | 3.9B -17.44% | 4.7B -11.74% | |
Total Long-Term Liabilities | 1.5B +60.52% | 917.0M +7.88% | 850.0M -3.19% | 878.0M +2.93% | |
Total Liabilities | 38.9B +9.14% | 35.6B +5.74% | 33.7B +10.33% | 30.6B +10.59% | |
Retained Earnings | 783.0M +373.78% | -286.0M -46.44% | -534.0M +90.71% | -280.0M -123.24% | |
Total Stockholders Equity | -2.8B -13.45% | -3.2B +12.66% | -2.9B +302.26% | -709.0M -139.59% | |
Total Shares Outstanding | 271.0M -17.13% | 327.0M 0.00% | 327.0M 0.00% | 327.0M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 2.4B -36.28% | 3.8B +32.51% | 2.8B -9.06% | 3.1B +28.53% | |
Capital Expenditures | 547.0M +7.05% | 511.0M +6.24% | 481.0M +24.29% | 387.0M -3.25% | |
Cash from Investing Activities | -5.6B +202.49% | -1.8B +307.27% | -454.0M -180.07% | 567.0M +250.00% | |
Dividends Paid | 494.0M -1.00% | 499.0M -4.95% | 525.0M -6.08% | 559.0M -2.44% | |
Cash from Financing Activities | 1.9B +329.04% | -847.0M -72.24% | -3.1B +23.87% | -2.5B +87.02% | |
Financials Ratio | |||||
Gross Margin | 3.67% +12.27% | 3.27% -2.73% | 3.36% -6.89% | 3.61% -13.50% | |
Operating Margin | 1.02% +86.51% | 0.55% +54.54% | 0.35% +207.91% | -0.33% -213.12% | |
Return on Assets | 3.18% +65.11% | 1.92% +221.84% | 0.60% +128.31% | -2.11% -247.32% | |
Return on Equity | -52.09% +85.39% | -28.10% +91.66% | -14.66% -91.50% | -172.46% -605.24% | |
Revenue Growth | -1.87% -117.60% | 10.64% -18.39% | 13.04% +12.10% | 11.63% +86.35% | |
Current Ratio | 0.94 -4.46% | 0.98 -2.49% | 1.00 -6.89% | 1.08 -4.08% | |
Cash Ratio | 0.10 -30.83% | 0.14 +20.10% | 0.12 -22.34% | 0.15 +25.22% | |
Debt-to-Equity Ratio | -3.07 +93.48% | -1.58 -3.85% | -1.65 -78.01% | -7.50 -315.30% | |
Debt-to-Assets Ratio | 0.16 +42.16% | 0.11 +4.25% | 0.11 -10.57% | 0.12 -13.68% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow